Thermo Fisher (TMO) Director Keith R. Alexandra Receives Award

What Happened

• Keith R. Alexandra, a director of Thermo Fisher Scientific (TMO), was granted 46.3 deferred stock units (reported as a derivative award) on September 26, 2026. The units were credited under the company's Deferred Compensation Plan for Directors at a per‑unit price of $675.00, representing an aggregate value of roughly $31,253. This was reported on a Form 4 filed September 29, 2026.

Key Details

• Transaction date: September 26, 2026; Form 4 filed: September 29, 2026.
• Transaction type/code: Award/Grant (A) — derivative stock units (not an open‑market buy or sale).
• Units granted: 46.3 deferred stock units; per‑unit price reported in footnote: $675.00; approximate value: $31,253.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes: F1 — units are convertible into common stock on a 1-for-1 basis. F2 — units were credited under the Issuer’s Deferred Compensation Plan for Directors; retainers are deferred quarterly as common stock units and shares are distributable upon cessation of director service or a change of control.

Context

• These are compensation units awarded to a director (routine director pay), not a market purchase or sale, and thus do not directly signal buying or selling sentiment. The units are a deferred award that becomes stock on departure from the board or upon a change in control, and are reported as a derivative grant rather than immediate ownership of common stock.